Global private equity and venture capital news and research

Posts Tagged ‘diagnostics.’

30 September 2014

Montagu to make 2x return in €1bn Euromedic exit deal $

blue-first-aid-box-911384-m European major Montagu Private Equity will double its money selling its stake in pan-European medical services provider Euromedic International, AltAssets has learned.

2 June 2014

Montagu, Astorg buy Sebia from Cinven for more than €1bn

euro Private equity firm Cinven has reportedly agreed to exit French diagnostics business Sebia to fellow private equity firms Montagu and Astorg.

2 April 2014

Pfizer Ventures, student-run Wolverine Venture Fund back $21m NeuMoDx Series B

wolverine-hugh-jackman-angel-investor Pfizer Ventures has led a $21m Series B round for diagnostics business NeuMoDx, which also included backing from the student-managed Wolverine Venture Fund.

31 March 2014

Carlyle acquires J&J’s diagnostics unit in $4bn deal

Private equity major Carlyle has agreed to buy Johnson & Johnson’s diganostics unit in a $4bn deal.

17 January 2014

Carlyle beats buyout competition to agree $4.15bn J&J diagnostics unit deal

BPL monitor Global buyout house The Carlyle Group has agreed a $4.15bn deal for Johnson & Johnson's diagnostics unit Ortho Clinical after fighting off competition from private equity peers.

3 December 2013

Molecular diagnostics company Xagenic raises $20m Series B

Panasonic HealthcareToronto-based molecular diagnostics company Xagenic has secured $20m in a Series B round led by new investor Domain Associates.

14 November 2013

Levine Leichtman acquires Genova Diagnostics in second deal from new fund

Private equity firm Levine Leichtman Capital Partners has bought Genova Diagnostics in the second deal from its fifth fund.

22 March 2013

Africa-focused Impala fund launches targeting 30% IRR $

While African businesses continue to offer huge growth potential, this cannot always be captured within a private equity context, according to Ugandan entrepreneur Jane Kaggwa.

10 April 2012

H.I.G. Capital raises $268m for life science venture fund

H.I.G. Capital has closed its H.I.G. BioVentures II fund on $268m, exceeding its $250m target. The fund invests as part of the global private equity group’s dedicated life science investment affiliate.

5 May 2011

Dutch BioGeneration Ventures raises second fund

Dutch venture capital firm BioGeneration Ventures has held an interim closing on its most recent life sciences BioGeneration Ventures II fund with a target of €30m. The fund has attracted existing and new LPs with backers including the Dutch Ministry of Economic Affairs, Agriculture and Innovation which invested through a TechnoPartner seed facility loan. The[...]

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015